Prognostic PET/CT Model in Non Small Cell Lung Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03199599
Recruitment Status : Unknown
Verified October 2017 by Poitiers University Hospital. Recruitment status was: Recruiting
First Posted : June 27, 2017
Last Update Posted : October 11, 2017
Poitiers University Hospital
Institut National de la Santé Et de la Recherche Médicale, France
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
150 patients with Non small cell lung cancer undergoing initial staging FDG PET/CT
non small cell lung cancer
initial fluorodeoxygluoces (FDG) PET/CT before treatment